Korean J Dermatol.
2020 Jun;58(5):330-333.
A Case of Sitagliptin Induced DRESS Syndrome
- Affiliations
-
- 1Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
Abstract
- Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an adverse drug reaction that is difficult to predict. It is characterized by fever, skin rash, and internal organ involvement that usually manifests 2∼6 weeks after use of the culprit drug. The antihyperglycemic agent sitagliptin is commonly used for treating diabetes mellitus, and sitagliptin-induced DRESS syndrome has not been previously reported in Korea. Herein, we report a case of DRESS syndrome after sitagliptin use; these observations may contribute to the timely diagnosis of sitagliptin induced DRESS syndrome and help reduce associated complications or morbidities.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Valproic Acid Induced DRESS Syndrome
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Ethambutol and Rifampin
- Three Cases of Allopurinol-induced DRESS Syndrome
- Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
- DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome induced by lamotrigine in a child
